Abbott Laboratories
NYSE:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abbott Laboratories
NYSE:ABT
|
US |
|
M
|
Myriad Genetics Inc
XMUN:MYD
|
US |
|
M
|
Merck KGaA
DUS:MRK
|
DE |
|
S
|
Sumitomo Realty & Development Co Ltd
DUS:RL2
|
JP |
|
Grupo Aeroportuario del Centro Norte SAB De CV
F:G7AB
|
MX |
|
L
|
London Stock Exchange Group PLC
XMUN:LS4C
|
UK |
|
C
|
Celanese Corp
XMUN:DG3
|
US |
|
InterContinental Hotels Group PLC
LSE:IHG
|
UK |
|
Bank Central Asia Tbk PT
IDX:BBCA
|
ID |
|
C
|
CaixaBank SA
SWB:48CA
|
ES |
|
Boeing Co
NYSE:BA
|
US |
|
Netscout Systems Inc
NASDAQ:NTCT
|
US |
|
X
|
Xiabuxiabu Catering Management (China) Holdings Co Ltd
OTC:XIAXF
|
CN |
|
H
|
Hudbay Minerals Inc
NYSE:HBM
|
CA |
|
T
|
Tokyo Gas Co Ltd
DUS:TOG
|
JP |
|
M
|
Merck KGaA
SWB:MRK
|
DE |
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
UBS Group AG
SIX:UBSG
|
CH |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
ChipMOS Technologies Inc
NASDAQ:IMOS
|
TW |
|
Midea Real Estate Holding Ltd
F:MR9
|
CN |
|
SBW
KRX:102280
|
KR |
Bankruptcy Probability
Abbott Laboratories's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Abbott Laboratories Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Abbott Laboratories
NYSE:ABT
|
178.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
117.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
103.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
62.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
127.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
31.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Abbott Laboratories's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Abbott Laboratories has total debt of 29.6B USD. This includes both short-term (0 USD) and long-term (29.6B USD) debt.
You can find a full breakdown on its Balance Sheet.
